Morinaga Milk Study Suggests Infant-Type Human-Residential Bifidobacteria May Benefit Infant Health by Improving Digestion of Peptides in Milk and Grains


Scientists at Morinaga Milk Industry Co. have long theorized that Human-Residential Bifidobacteria  (HRB) are superior to non-Human-https://mms.businesswire.com/media/20181023005015/en/684616/5/1.jpg?download=1Residential Bifidobacteria (non-HRB) in promoting good health outcomes. The results of a new study strengthen the evidence for this theory, showing that infant-type HRB may be able to break down incompletely digested peptides in the infants’ gastrointestinal systems and thus contribute to their overall health. Morinaga Milk has been conducting research on bifidobacteria for many years, and studies over the past decades have shown that bifidobacteria play a vital role in various aspects of human health. There are two major groups of bifidobacteria: Human-Residential Bifidobacteria, which naturally reside in the human intestines, especially in infants, and non-Human-Residential Bifidobacteria, which are natural inhabitants of animals or the environment….. Read

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.